Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2016: 1.000
Source Normalized Impact per Paper (SNIP) 2016: 1.112

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 52, Issue 5 (May 2014)

Issues

Routine use of the Ion Torrent AmpliSeq™ Cancer Hotspot Panel for identification of clinically actionable somatic mutations

Gregory J. Tsongalis
  • Corresponding author
  • Department of Pathology, Geisel School of Medicine at Dartmouth and Dartmouth Hitchcock Medical Center, Lebanon, NH, USA
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Jason D. Peterson
  • Department of Pathology, Geisel School of Medicine at Dartmouth and Dartmouth Hitchcock Medical Center, Lebanon, NH, USA
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Francine B. de Abreu
  • Department of Pathology, Geisel School of Medicine at Dartmouth and Dartmouth Hitchcock Medical Center, Lebanon, NH, USA
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Christopher D. Tunkey
  • Department of Pathology, Geisel School of Medicine at Dartmouth and Dartmouth Hitchcock Medical Center, Lebanon, NH, USA
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Torrey L. Gallagher
  • Department of Pathology, Geisel School of Medicine at Dartmouth and Dartmouth Hitchcock Medical Center, Lebanon, NH, USA
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Linda D. Strausbaugh / Wendy A. Wells
  • Department of Pathology, Geisel School of Medicine at Dartmouth and Dartmouth Hitchcock Medical Center, Lebanon, NH, USA
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Christopher I. Amos
  • Departments of Medicine and Community and Family Medicine, Geisel School of Medicine at Dartmouth and Dartmouth Hitchcock Medical Center, Lebanon, NH, USA
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2013-12-13 | DOI: https://doi.org/10.1515/cclm-2013-0883

Abstract

Background: Somatic mutation analysis is standard of practice for solid tumors in order to identify therapeutic sensitizing and resistance mutations. Our laboratory routinely performed standalone PCR-based methods for mutations in several genes. Rapid discovery and introduction of new therapeutics has demanded additional genomic information for adequate management of the cancer patient. We evaluated a next generation sequencing assay, the Ion Torrent AmpliSeq Cancer Hotspot Panelv2 (CHPv2), capable of identifying multiple somatic mutations in 50 genes in a single assay.

Methods: Accuracy, precision, limit of detection, and specificity were evaluated using DNA from well-characterized cell lines, genetically engineered cell lines fixed and embedded in paraffin, and previously tested mutation positive or negative, formalin-fixed, paraffin-embedded (FFPE) tissues. Normal kidney, tonsil and colon FFPE tissues were used as controls.

Results: Accuracy studies showed 100% concordance in each patient sample between previous PCR results and the corresponding variants identified using the Ion Torrent panel. Precision studies gave consistent results when libraries were prepared from the same original DNA and were run on multiple 316 chips. The limit of detection was determined to be 5% for single nucleotide variants (SNVs) and 20% for insertions and deletions (indels). Specificity studies using normal FFPE tissue previously tested by PCR methods were also 100%.

Conclusions: We have evaluated the performance of the AmpliSeq Cancer Panel Hotspotv2 and show that it is suitable for clinical testing. This next generation sequencing panel has allowed the laboratory to consolidate a broader range of molecular oncology testing to a single platform and single assay.

Keywords: cancer; colon cancer; glioma; lung cancer; melanoma; next generation sequencing; somatic mutations

References

  • 1.

    Tuononen K, Mäki-Nevala S, Sarhadi VK, Wirtanen A, Rönty M, Salmenkivi K, et al. Comparison of targeted next-generation sequencing (NGS) and real-time PCR in the detection of EGFR, KRAS, and BRAF mutations on formalin-fixed, paraffin-embedded tumor material of non-small cell lung carcinoma-superiority of NGS. Genes Chromosomes Cancer 2013;5:503–11.Web of ScienceCrossrefGoogle Scholar

  • 2.

    Peeters M, Oliner KS, Parker A, Siena S, Van Cutsem E, Huang J, et al. Massively parallel tumor multigene sequencing to evaluate response to panitumumab in a randomized phase III study of metastatic colorectal cancer. Clin Cancer Res 2013;19:1902–12.CrossrefGoogle Scholar

  • 3.

    Amado RG, Wolf M, Peeters M, Van Cutsem E, Siena S, Freeman DJ, et al. Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer. J Clin Oncol 2008;26:1626–34.PubMedCrossrefGoogle Scholar

  • 4.

    Tol J, Koopman M, Cats A, Rodenburg CJ, Creemers GJ, Schrama JG, et al. Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer. N Engl J Med 2009;360:563–72.Web of ScienceGoogle Scholar

  • 5.

    Di Nicolantonio F, Martini M, Molinari F, Sartore-Bianchi A, Arena S, Saletti P, et al. Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer. J Clin Oncol 2008;26:5705–12.CrossrefPubMedGoogle Scholar

  • 6.

    Paez JG, Jänne PA, Lee JC, Tracy S, Greulich H, Gabriel S, et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 2004;304:1497–500.Google Scholar

  • 7.

    Hudis CA. Trastuzumab – mechanism of action and use in clinical practice. N Engl J Med 2007;357:39–51.Google Scholar

  • 8.

    Walther A, Johnstone E, Swanton C, Midgley R, Tomlinson I, Kerr D. Genetic prognostic and predictive markers in colorectal cancer. Nat Rev Cancer 2009;9:489–99.CrossrefPubMedWeb of ScienceGoogle Scholar

  • 9.

    Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, et al. Mutations of the BRAF gene in human cancer. Nature 2002;417:949–54.Google Scholar

  • 10.

    Eberhard DA, Johnson BE, Amler LC, Goddard AD, Heldens SL, Herbst RS, et al. Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib. J Clin Oncol 2005;23:5900–9.PubMedCrossrefGoogle Scholar

  • 11.

    Pao W, Miller VA. Epidermal growth factor receptor mutations, small-molecule kinase inhibitors, and non-small-cell lung cancer: current knowledge and future directions. J Clin Oncol 2005;23:2556–68.CrossrefPubMedGoogle Scholar

  • 12.

    Sequist LV, Joshi VA, Jänne PA, Muzikansky A, Fidias P, Meyerson M, et al. Response to treatment and survival of patients with non-small cell lung cancer undergoing somatic EGFR mutation testing. Oncologist 2007;12:90–8.CrossrefWeb of SciencePubMedGoogle Scholar

  • 13.

    Marks JL, Broderick S, Zhou Q, Chitale D, Li AR, Zakowski MF, et al. Prognostic and therapeutic implications of EGFR and KRAS mutations in resected lung adenocarcinoma. J Thorac Oncol 2008;3:111–6.CrossrefPubMedGoogle Scholar

  • 14.

    Siegfried JM, Gillespie AT, Mera R, Casey TJ, Keohavong P, Testa JR, et al. Prognostic value of specific KRAS mutations in lung adenocarcinomas. Cancer Epidemiol Biomarkers Prev 1997;6:841–7.PubMedGoogle Scholar

  • 15.

    Wertheim GB, Daber R, Bagg A. Molecular diagnostics of acute myeloid leukemia: it’s a (next) generational thing. J Mol Diagn 2013;1:27–30.CrossrefGoogle Scholar

  • 16.

    Spencer DH, Abel HJ, Lockwood CM, Payton JE, Szankasi P, Kelley TW, et al. Detection of FLT3 internal tandem duplication in targeted, short-read-length, next-generation sequencing data. J Mol Diagn 2013;1:81–93.Google Scholar

  • 17.

    Metzker ML. Sequencing technologies – the next generation. Nat Rev Genet 2010;11:31–46.CrossrefPubMedGoogle Scholar

  • 18.

    Quail MA, Smith M, Coupland P, Otto TD, Harris SR, Connor TR, et al. A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequencers. BMC Genomics 2012;13:341.CrossrefPubMedGoogle Scholar

  • 19.

    Hadd AG, Houghton J, Choudhary A, Sah S, Chen L, Marko AC, et al. Targeted, high-depth, next-generation sequencing of cancer genes in formalin-fixed, paraffin-embedded and fine-needle aspiration tumor specimens. J Mol Diagn 2013;2:234–47.CrossrefGoogle Scholar

  • 20.

    Beadling C, Neff TL, Heinrich MC, Rhodes K, Thornton M, Leamon J, et al. Combining highly multiplexed PCR with semiconductor-based sequencing for rapid cancer genotyping. J Molec Diagn 2013;15:171–6.CrossrefGoogle Scholar

  • 21.

    Singh RR, Patel KP, Routbort MJ, Reddy NG, Barkoh BA, Handal B, et al. Clinical validation of a next generation sequencing screen for mutational hotspots in 46 cancer related genes. J Molec Diagn 2013;15:607–22.CrossrefGoogle Scholar

  • 22.

    Merriman B, Ion Torrent R&D Team, Rothberg JM. Progress in ion torrent semiconductor chip based sequencing. Electrophoresis 2012;33:3397–417.CrossrefWeb of ScienceGoogle Scholar

  • 23.

    Rothberg JM, Hinz W, Rearick TM, Schultz J, Mileski W, Davey M, et al. An integrated semiconductor device enabling non-optical genome sequencing. Nature 2011;475:348–52.Web of ScienceGoogle Scholar

  • 24.

    Yousem SA, Dacic S, Nikiforov YE, Nikiforova M. Pulmonary Langerhans cell histiocytosis: profiling of multifocal tumors using next-generation sequencing identifies concordant occurrence of BRAF V600E mutations. Chest 2013;143:1679–84.Web of ScienceGoogle Scholar

  • 25.

    Lièvre A, Bachet JB, Boige V, Cayre A, Le Corre D, Buc E, et al. KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab. J Clin Oncol 2008;26:374–9.PubMedCrossrefGoogle Scholar

  • 26.

    Jarry A, Masson D, Cassagnau E, Parois S, Laboisse C, Denis MG. Real-time allele-specific amplification for sensitive detection of the BRAF mutation V600E. Mol Cell Probes 2004;18:349–52.Google Scholar

  • 27.

    Pan Q, Pao W, Ladanyi M. Rapid polymerase chain reaction-based detection of epidermal growth factor receptor gene mutations in lung adenocarcinomas. J Mol Diagn 2005;7:396–403.CrossrefPubMedGoogle Scholar

  • 28.

    Robinson JT, Thorvaldsdóttir H, Winckler W, Guttman M, Lander ES, Getz G, et al. Integrative genomics viewer. Nat Biotechnol 2011;29:24–6.Web of SciencePubMedCrossrefGoogle Scholar

  • 29.

    Kaushal D, Naeve CW. An overview of Spotfire for gene-expression studies. Curr Protoc Bioinformatics 2004;7:7.7.PubMedCrossrefGoogle Scholar

  • 30.

    Forbes SA, Bindal N, Bamford S, Cole C, Kok CY, Beare D, et al. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res 2011;39:D945–50.Web of ScienceCrossrefGoogle Scholar

  • 31.

    Worthey EA, Mayer AN, Syverson GD, Helbling D, Bonacci BB, Decker B, et al. Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease. Genet Med 2011;3:255–62.CrossrefWeb of ScienceGoogle Scholar

About the article

Corresponding author: Gregory J. Tsongalis, Department of Pathology, Geisel School of Medicine at Dartmouth and Dartmouth Hitchcock Medical Center, 1 Medical Center Drive, Lebanon, NH 03756, USA, Phone: +1 603 650 5498, E-mail:


Received: 2013-10-14

Accepted: 2013-11-23

Published Online: 2013-12-13

Published in Print: 2014-05-01


Citation Information: Clinical Chemistry and Laboratory Medicine, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/cclm-2013-0883.

Export Citation

©2014 by Walter de Gruyter Berlin/Boston. Copyright Clearance Center

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[2]
Choong-kun Lee, Sora Kim, Jae Seok Lee, Jeong Eun Lee, Sung-moo Kim, In Seok Yang, Hye Ryun Kim, Jeong Ho Lee, Sangwoo Kim, and Byoung Chul Cho
Lung Cancer, 2017, Volume 113, Page 106
[3]
Gregory J. Tsongalis and William B. Coleman
The Journal of Clinical Pharmacology, 2017, Volume 57, Page S60
[4]
Allen P. Miraflor, Francine B. de Abreu, Jason D. Peterson, Scott A. Turner, Christopher I. Amos, Gregory J. Tsongalis, and Shaofeng Yan
Experimental and Molecular Pathology, 2017
[5]
Karen L. Kaul, Linda M. Sabatini, Gregory J. Tsongalis, Angela M. Caliendo, Randall J. Olsen, Edward R. Ashwood, Sherri Bale, Robert Benirschke, Dean Carlow, Birgit H. Funke, Wayne W. Grody, Randall T. Hayden, Madhuri Hegde, Elaine Lyon, Kazunori Murata, Melissa Pessin, Richard D. Press, and Richard B. Thomson
Academic Pathology, 2017, Volume 4, Page 237428951770830
[6]
Joonhong Park, Han Mo Yoo, Woori Jang, Soyoung Shin, Myungshin Kim, Yonggoo Kim, Seung-Woo Lee, and Jeong Goo Kim
Medicine, 2017, Volume 96, Number 25, Page e7224
[7]
Simon A. Hardwick, Ira W. Deveson, and Tim R. Mercer
Nature Reviews Genetics, 2017, Volume 18, Number 8, Page 473
[8]
Blanca de Unamuno Bustos, Rosa Murria Estal, Gema Pérez Simó, Inmaculada de Juan Jimenez, Begoña Escutia Muñoz, Mercedes Rodríguez Serna, Victor Alegre de Miquel, Margarita Llavador Ros, Rosa Ballester Sánchez, Eduardo Nagore Enguídanos, Sarai Palanca Suela, and Rafael Botella Estrada
Scientific Reports, 2017, Volume 7, Number 1
[9]
Vijayalakshmi Padmanabhan, Heather B. Steinmetz, Elizabeth J. Rizzo, Amber J. Erskine, Tamara L. Fairbank, Francine B. de Abreu, Gregory J. Tsongalis, and Laura J. Tafe
Archives of Pathology & Laboratory Medicine, 2017, Volume 141, Number 3, Page 402
[10]
Rick Kamps, Rita Brandão, Bianca Bosch, Aimee Paulussen, Sofia Xanthoulea, Marinus Blok, and Andrea Romano
International Journal of Molecular Sciences, 2017, Volume 18, Number 2, Page 308
[11]
Angela Hamblin, Sarah Wordsworth, Jilles M. Fermont, Suzanne Page, Kulvinder Kaur, Carme Camps, Pamela Kaisaki, Avinash Gupta, Denis Talbot, Mark Middleton, Shirley Henderson, Anthony Cutts, Dimitrios V. Vavoulis, Nick Housby, Ian Tomlinson, Jenny C. Taylor, Anna Schuh, and Marc Ladanyi
PLOS Medicine, 2017, Volume 14, Number 2, Page e1002230
[12]
Ken J. Hampel, Francine B. de Abreu, Nikoletta Sidiropoulos, Jason D. Peterson, and Gregory J. Tsongalis
Experimental and Molecular Pathology, 2017, Volume 102, Number 2, Page 215
[13]
Mariana Brait, Evgeny Izumchenko, Luciane T Kagohara, Samuel Long, Piotr T Wysocki, Brian Faherty, Elana J Fertig, Tin Oo Khor, Elizabeth Bruckheimer, Gilson Baia, Daniel Ciznadija, Ido Sloma, Ido Ben-Zvi, Keren Paz, and David Sidransky
British Journal of Cancer, 2017, Volume 116, Number 4, Page 515
[14]
Arnaud Da Cruz Paula, Catarina Leitão, Oriana Marques, Ana Margarida Rosa, Ana Helena Santos, Alexandra Rêma, Maria de Fátima Faria, Ana Rocha, José Luís Costa, Margarida Lima, and Carlos Lopes
Virchows Archiv, 2017, Volume 470, Number 3, Page 311
[15]
Viktor H. Koelzer, Karl Steuer, Ulrike Camenisch Gross, Dieter Zimmermann, Aino Paasinen-Sohns, Kirsten D. Mertz, and Gieri Cathomas
Frontiers in Oncology, 2016, Volume 6
[16]
Sabah Kadri, Bradley C. Long, Ibro Mujacic, Chao J. Zhen, Michelle N. Wurst, Shruti Sharma, Nadia McDonald, Nifang Niu, Sonia Benhamed, Jigyasa H. Tuteja, Tanguy Y. Seiwert, Kevin P. White, Megan E. McNerney, Carrie Fitzpatrick, Y. Lynn Wang, Larissa V. Furtado, and Jeremy P. Segal
The Journal of Molecular Diagnostics, 2017, Volume 19, Number 1, Page 43
[17]
Niall J. Lennon, Viktor A. Adalsteinsson, and Stacey B. Gabriel
Genome Medicine, 2016, Volume 8, Number 1
[18]
Gerald W. Prager, Oskar Koperek, Marius E. Mayerhoefer, Leonhard Muellauer, Fritz Wrba, Bruno Niederle, Christoph C. Zielinski, and Markus Raderer
Thyroid, 2016, Volume 26, Number 10, Page 1515
[19]
Laura J. Tafe, Kirsten J. Pierce, Jason D. Peterson, Francine de Abreu, Vincent A. Memoli, Candice C. Black, Jason R. Pettus, Jonathan D. Marotti, Edward J. Gutmann, Xiaoying Liu, Keisuke Shirai, Konstantin H. Dragnev, Christopher I. Amos, and Gregory J. Tsongalis
Neoplasia, 2016, Volume 18, Number 9, Page 577
[20]
Emily M. Kudalkar, Naif A.M. Almontashiri, Catherine Huang, Bharathi Anekella, Mark Bowser, Elizabeth Hynes, Russell Garlick, and Birgit H. Funke
The Journal of Molecular Diagnostics, 2016, Volume 18, Number 6, Page 882
[21]
Nadezda P. Velizheva, Markus P. Rechsteiner, Christine E. Wong, Qing Zhong, Matthias Rössle, Beata Bode, Holger Moch, Alex Soltermann, Peter J. Wild, and Verena Tischler
Cancer Cytopathology, 2017, Volume 125, Number 1, Page 30
[22]
[23]
Ahmad N. Abou Tayoun, Bryan Krock, and Nancy B. Spinner
Expert Review of Molecular Diagnostics, 2016, Volume 16, Number 9, Page 987
[24]
K.J. Pierce, F.B. de Abreu, J.D. Peterson, A.A. Suriawinata, G.J. Tsongalis, and X. Liu
Experimental and Molecular Pathology, 2016, Volume 101, Number 2, Page 172
[25]
Brunella Pilato, Rosamaria Pinto, Simona De Summa, Daniela Petriella, Rosanna Lacalamita, Katia Danza, Angelo Paradiso, and Stefania Tommasi
Genes, Chromosomes and Cancer, 2016, Volume 55, Number 10, Page 803
[26]
Jie Gao, Huanwen Wu, Li Wang, Hui Zhang, Huanli Duan, Junliang Lu, and Zhiyong Liang
BMJ Open, 2016, Volume 6, Number 1, Page e009532
[27]
Andrei-Tudor Cernomaz, Ina Iuliana Macovei, Ionut Pavel, Carmen Grigoriu, Mihai Marinca, Florent Baty, Simona Peter, Radu Zonda, Martin Brutsche, and Bogdan- Dragos Grigoriu
BMC Pulmonary Medicine, 2016, Volume 16, Number 1
[28]
Ke Chen, Yu-xun Zhou, Kai Li, Li-xin Qi, Qi-fei Zhang, Mao-chun Wang, and Jun-hua Xiao
Analytical and Bioanalytical Chemistry, 2016, Volume 408, Number 16, Page 4371
[29]
Kristen E. Muller, Jonathan D. Marotti, Francine B. de Abreu, Jason D. Peterson, Todd W. Miller, Mary D. Chamberlin, Gregory J. Tsongalis, and Laura J. Tafe
Experimental and Molecular Pathology, 2016, Volume 100, Number 3, Page 421
[30]
Anna Biernacka, Peter D. Tsongalis, Jason D. Peterson, Francine B. de Abreu, Candice C. Black, Edward J. Gutmann, Xiaoying Liu, Laura J. Tafe, Christopher I. Amos, and Gregory J. Tsongalis
Cancer Genetics, 2016, Volume 209, Number 5, Page 195
[31]
Scott A. Turner, Jason D. Peterson, Jason R. Pettus, Francine B. de Abreu, Christopher I. Amos, Konstantin H. Dragnev, and Gregory J. Tsongalis
The Journal of Molecular Diagnostics, 2016, Volume 18, Number 3, Page 331
[32]
Roza Bidshahri, Dean Attali, Kareem Fakhfakh, Kelly McNeil, Aly Karsan, Jennifer R. Won, Robert Wolber, Jennifer Bryan, Curtis Hughesman, and Charles Haynes
The Journal of Molecular Diagnostics, 2016, Volume 18, Number 2, Page 190
[33]
M. Rechsteiner, P. Wild, M. K. Kiessling, A. Bohnert, Q. Zhong, R. A. Stahel, H. Moch, and A. Curioni-Fontecedro
Annals of Oncology, 2015, Volume 26, Number 1, Page 246
[34]
E. Vigliar, U. Malapelle, C. de Luca, C. Bellevicine, and G. Troncone
Cytopathology, 2015, Volume 26, Number 5, Page 271
[35]
Catherine I. Dumur, Jorge A. Almenara, Celeste N. Powers, and Andrea Ferreira-Gonzalez
Diagnostic Pathology, 2015, Volume 10, Number 1
[36]
Brian R. Lane, Jeffrey Bissonnette, Tracy Waldherr, Deborah Ritz-Holland, Dave Chesla, Sandra L. Cottingham, Sheryl Alberta, Cong Liu, Amanda B. Thompson, Carrie Graveel, Jeffrey P. MacKeigan, Sabrina L. Noyes, Judy Smith, Nehal Lakhani, Matthew R. Steensma, Mark Enter, Kimberly Mohr, Samer Al-Homsi, Stephanie Williams, Marlee Bogema, Kirk Gates, Marianne Melnik, Mathew Chung, Thomas Southwell, Anne Wilds, Kimberly Collison, Timothy O'Rourke, Amy VanderWoude, Alan Campbell, Mark Campbell, Brett Brinker, Julian Schink, Leigh Seamon, and Mary Winn
The Journal of Molecular Diagnostics, 2015, Volume 17, Number 6, Page 695
[37]
Ian S. Hagemann, Patrick K. O'Neill, Ivan Erill, and John D. Pfeifer
Cancer Genetics, 2015, Volume 208, Number 9, Page 441
[38]
Juan Putra, Francine B. de Abreu, Jason D. Peterson, J. Marc Pipas, Kabir Mody, Christopher I. Amos, Gregory J. Tsongalis, and Arief A. Suriawinata
Experimental and Molecular Pathology, 2015, Volume 99, Number 2, Page 240
[39]
Ming Wang, Leire Escudero-Ibarz, Sarah Moody, Naiyan Zeng, Alexandra Clipson, Yuanxue Huang, Xuemin Xue, Nicholas F. Grigoropoulos, Sharon Barrans, Lisa Worrillow, Tim Forshew, Jing Su, Andrew Firth, Howard Martin, Andrew Jack, Kim Brugger, and Ming-Qing Du
The Journal of Molecular Diagnostics, 2015, Volume 17, Number 5, Page 521
[40]
Claudio Bellevicine, Elena Vigliar, Umberto Malapelle, Emanuele Carelli, Alfonso Fiorelli, Giovanni Vicidomini, Salvatore Cappabianca, Mario Santini, and Giancarlo Troncone
Diagnostic Cytopathology, 2015, Volume 43, Number 7, Page 585
[41]
Donavan T. Cheng, Talia N. Mitchell, Ahmet Zehir, Ronak H. Shah, Ryma Benayed, Aijazuddin Syed, Raghu Chandramohan, Zhen Yu Liu, Helen H. Won, Sasinya N. Scott, A. Rose Brannon, Catherine O'Reilly, Justyna Sadowska, Jacklyn Casanova, Angela Yannes, Jaclyn F. Hechtman, Jinjuan Yao, Wei Song, Dara S. Ross, Alifya Oultache, Snjezana Dogan, Laetitia Borsu, Meera Hameed, Khedoudja Nafa, Maria E. Arcila, Marc Ladanyi, and Michael F. Berger
The Journal of Molecular Diagnostics, 2015, Volume 17, Number 3, Page 251
[42]
Francesca Belardinilli, Carlo Capalbo, Amelia Buffone, Marialaura Petroni, Valeria Colicchia, Sergio Ferraro, Massimo Zani, Arianna Nicolussi, Sonia D'Inzeo, Anna Coppa, Isabella Screpanti, Alberto Gulino, and Giuseppe Giannini
Clinical Biochemistry, 2015, Volume 48, Number 13-14, Page 908
[43]
Claus Børsting and Niels Morling
Forensic Science International: Genetics, 2015, Volume 18, Page 78
[44]
Shin-Ya Nishio, Yoshiharu Hayashi, Manabu Watanabe, and Shin-Ichi Usami
Genetic Testing and Molecular Biomarkers, 2015, Volume 19, Number 4, Page 209
[45]
Guruprasad Ananda, Susan Mockus, Micaela Lundquist, Vanessa Spotlow, Al Simons, Talia Mitchell, Grace Stafford, Vivek Philip, Timothy Stearns, Anuj Srivastava, Mary Barter, Lucy Rowe, Joan Malcolm, Carol Bult, Radha Krishna Murthy Karuturi, Karen Rasmussen, and Douglas Hinerfeld
Experimental and Molecular Pathology, 2015, Volume 98, Number 1, Page 106
[46]
Nathan R. Campbell, Stephanie A. Harmon, and Shawn R. Narum
Molecular Ecology Resources, 2015, Volume 15, Number 4, Page 855
[47]
Kristen E. Muller, Laura J. Tafe, Francine B. de Abreu, Jason D. Peterson, Wendy A. Wells, Richard J. Barth, and Jonathan D. Marotti
Human Pathology, 2015, Volume 46, Number 2, Page 327
[48]
Catherine I. Dumur
Cancer Cytopathology, 2014, Volume 122, Number 10, Page 730
[49]
Nabil F. Saba, Malania Wilson, Gregory Doho, Juliana DaSilva, R. Benjamin Isett, Scott Newman, Zhuo Georgia Chen, Kelly Magliocca, and Michael R. Rossi
Head and Neck Pathology, 2015, Volume 9, Number 2, Page 223
[50]
Paul Lochhead, Andrew T Chan, Edward Giovannucci, Charles S Fuchs, Kana Wu, Reiko Nishihara, Michael O'Brien, and Shuji Ogino
The American Journal of Gastroenterology, 2014, Volume 109, Number 8, Page 1205

Comments (0)

Please log in or register to comment.
Log in